Science

Immune-mediated liver injury by Immune checkpoint inhibitors

Evangelos Triantafyllou, Cathrin L. C. Gudd and Lucia A. Possamai

Dec 16, 2024, 12:23

Immune-mediated liver injury by Immune checkpoint inhibitors

Erman Akkus, Medical Oncology fellow at Ankara University, shared a recent article by Evangelos Triantafyllou on X:

“Immune-mediated liver injury by Immune checkpoint inhibitor (ICIs) in Nature Reviews Gastroenterology and Hepatology.

From mechanisms to treatment.”

Title: Immune-mediated liver injury from checkpoint inhibitors: mechanisms, clinical characteristics and management

Authors: Evangelos Triantafyllou, Cathrin L. C. Gudd and Lucia A. Possamai

liver injury

Erman Akkus is a medical oncology fellow at the Ankara University, Faculty of Medicine. Previously, he was an Internal Medicine Resident at the Ankara University, Faculty of Medicine. He was also a Visiting Researcher at the University of Oslo. He completed his education from the Medical University of Vienna.

More posts featuring Erman Akkus.

cancer Cathrin L. C. Gudd Erman Akkus Evangelos Triantafyllou Gastroenterology Hepatology ICIs liver injury Lucia A. Possamai Nature Reviews OncoDaily Oncology

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity